Fulgent Genetics (FLGT) EBITDA Margin Growth (1y) (2016 - 2026)
Fulgent Genetics (FLGT) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -2,667.00 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 37.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 39.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 8.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 376.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 110.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -57.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 340.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 151.00 |
| 10 | Fulgent Genetics | 570.68 Mn | 288.72 Mn | 21.49 Mn | -2,172.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,172.00 |
| Dec 31, 2025 | -10,383.00 |
| Sep 30, 2025 | 555.00 |
| Jun 30, 2025 | 252.00 |
| Mar 31, 2025 | 686.00 |
| Dec 31, 2024 | 19,317.00 |
| Sep 30, 2024 | -2,406.00 |
| Jun 30, 2024 | 256.00 |
| Mar 31, 2024 | 371.00 |
| Sep 30, 2023 | -8.00 |
| Jun 30, 2023 | -3,939.00 |
| Mar 31, 2023 | -10,057.00 |
| Sep 30, 2022 | -6,956.00 |
| Jun 30, 2022 | -5,417.00 |
| Mar 31, 2022 | -1,121.00 |
| Dec 31, 2021 | -1,664.00 |
| Sep 30, 2021 | 745.00 |
| Jun 30, 2021 | 4,909.00 |
| Mar 31, 2021 | 9,895.00 |
| Dec 31, 2020 | 8,146.00 |